Daniel Abramovicz
Impact in
- Rheumatology top 0.5%
- Systemic Lupus Erythematosus Research
- Nephrology top 1%
- Renal Diseases and Glomerulopathies
Papers in
-
- Renal Transplantation Outcomes and Treatments 4
-
- Systemic Lupus Erythematosus Research 5
- Co-authors
- François C. Berthoux (2 shared papers)Lorna Paul (1 shared paper)Henrik Ekberg (1 shared paper)Klaus Ølgaard (1 shared paper)Ulrich A. Frei (1 shared paper)Nicole Lefrançois (1 shared paper)Denis Glotz (1 shared paper)Philippe Lang (1 shared paper)
In The Last Decade
Daniel Abramovicz
11 papers receiving 2.2k citations
Daniel Abramovicz's Hit Papers
Peers
Comparison fields: 5 of 66
- Rheumatology 1.4k
- Nephrology 640
- Transplantation 180
- Hepatology 355
- Hematology 341
Countries citing papers authored by Daniel Abramovicz
This map shows the geographic impact of Daniel Abramovicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Abramovicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Abramovicz more than expected).
Fields of papers citing papers by Daniel Abramovicz
This network shows the impact of papers produced by Daniel Abramovicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Abramovicz. The network helps show where Daniel Abramovicz may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Abramovicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide Hit paper breakdown → | 2002 | 816 |
| 2 | The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide Hit paper breakdown → | 2009 | 414 |
| 3 | 2013 | 354 | |
| 4 | European Best Practice Guidelines for Renal Transplantation (Part 2). | 2002 | 339 |
| 5 | 2004 | 320 | |
| 6 | 2010 | 53 | |
| 7 | Lessons from the "Euro-Lupus Cohort". | 2002 | 23 |
| 8 | Long-term outcome of patients randomized in the euro-lupus nephritis trial: Further evidence that a low-dose IV cyclophosphamide induction regimen achieves good results | 2006 | 5 |
| 9 | 2008 | 3 | |
| 10 | BELGIAN EXPERIENCE OF DCD KIDNEY TRANSPLANTATION | 2011 | 3 |
| 11 | 2023 | 2 |
About Daniel Abramovicz
Daniel Abramovicz is a scholar working on Transplantation, Rheumatology, Clinical Biochemistry, Nephrology and Hepatology, having authored 11 papers that have together received 2.3k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (5 papers), Renal Transplantation Outcomes and Treatments (4 papers), Organ Transplantation Techniques and Outcomes (2 papers), Metabolism and Genetic Disorders (2 papers), Organ Donation and Transplantation (2 papers), Erythropoietin and Anemia Treatment (1 paper), Iron Metabolism and Disorders (1 paper) and Hemoglobinopathies and Related Disorders (1 paper). The work is most often cited by research in Rheumatology (1.4k citations), Nephrology (640 citations), Transplantation (180 citations), Hepatology (355 citations) and Hematology (341 citations). Daniel Abramovicz has collaborated with scholars based in Belgium, Spain and Italy. Frequent co-authors include François C. Berthoux, Lorna Paul, Henrik Ekberg, Klaus Ølgaard, Ulrich A. Frei, Nicole Lefrançois, Denis Glotz, Philippe Lang, Yves F. Ch. Vanrenterghem and Gérard Rifle. Their work appears in journals such as Annals of the Rheumatic Diseases, Transplantation, Nephrology Dialysis Transplantation, Transplantation Reviews and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.